Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

SPB Exchange resumes trading

2/24/25 SPBE

On SPB Exchange there was a glitch

2/24/25 SPBE

Nornickel to launch new cobalt production in 2025

2/21/25 GMKN

Moscow Exchange to launch Russia's first wine index

2/21/25 MOEX

Softline develops the industrial software business

2/21/25 SOFL

Nextgen has begun research on a drug to treat baldness

2/21/25 ABIO

RSC Energia started placement of additional share issue

2/21/25 RKKE

Raspadskaya reports for 2024 by IFRS

2/21/25 RASP

Promomed expects demand for obesity drug to grow 10-fold

2/20/25 PRMD

Samolet launches the market's first ready-to-rent business with its own apartments

2/20/25 SMLT